Findings lay the groundwork for developing targeted therapies aimed at regulating epigenetic factors in cancer therapy.
Now that’s cool but you will probably only see rich people flying in it for a while, if it comes to be.
The supersonic, nuclear-powered plane concept flies nearly twice the speed of Concorde and could get from London to New York in less time than a soccer game.
More than a century ago, a wild-eyed, vegetarian, free love-promoting German entrepreneur and self-taught economist named Silvio Gesell proposed a radical reformation of the monetary system as we know it.
A long-forgotten German economist argued that society and the economy would be better off if money was a perishable good. Was he an anarchist crank or the prophet of a better world?
Scientists from the UK and South Korea have discovered a way to create laser pulses 1,000 times stronger than currently possible. Using computer simulations, they have discovered that a new way of compressing the light can drastically increase its intensity to such an extent that it can extract particles from a vacuum. This new technique could open up doors for important discoveries into the very nature of matter.
Uncover the nature of matter
Continue reading “Scientists find new way to supercharge lasers by a million times” »
Warren Buffett, the venerated investor and CEO of Berkshire Hathaway, is set to amass over $6 billion in dividend income in the coming year, with a significant portion of this windfall emanating from just three stocks. This substantial income stream underscores the effectiveness of Buffett’s investment strategy, one that favors profitability and long-term value.
Buffett’s predilection for dividend-bearing stocks isn’t just a matter of preference; it’s a testament to his investment acumen. Among his top dividend earners, Bank of America Corp BAC stands out, with expected dividend earnings of approximately $991.5 million. A leading financial institution, BofA has thrived in the higher interest rate environment, seeing a substantial increase in its net-interest income.
“Whoever leads in AI will rule the world,” President Vladimir Putin declared at an address commencing the 2017 Russian school year. Six years later, despite intense focus from senior leadership and heavy investment from the federal budget and state-owned enterprises, Russia remains a laggard in this field, hobbled by international isolation and structural challenges.
Military, political, and business leaders in Moscow have long understood the importance of controlling the information space to secure their grasp on power. After the scare of social media powered “color revolutions” on Russia’s doorstep, Moscow doubled down on these efforts. But facing both headwinds intrinsic to the nature of generative AI and deep, self-inflicted wounds from the war in Ukraine, the window for Russia to take a lead is closing quickly.
Russia’s leaders were caught flat-footed by the rise of social media. The supposed dangers of emerging technology were brought to the fore by Chisinau’s so-called “ Twitter revolution,” when protests organized in part on American social networks prevented Moldova’s ardently pro-Russian Party of Communists from winning the election in 2009.
The one-time treatment helped relieve symptoms of disease and could free patients from the need for bone marrow transplants or regular blood transfusions, Beach said, adding that the drug hopefully offers a permanent fix for the condition.
The MHRA said it identified no significant safety concerns during the trials and will continue to closely monitor Casgevy’s safety after approval.
Vertex CEO and President Reshma Kewalramanit celebrated Casgevy’s approval as “a historic day in science and medicine” and Samarth Kulkarni, CEO and Chairman of Crispr Therapeutics, said it will hopefully mark “the first of many applications of this Nobel Prize winning technology to benefit eligible patients with serious diseases.” The two companies are hoping for similarly positive decisions from the MHRA’s counterparts in the Europe Union and the U.S., which are in the process of evaluating Casgevy, also known as exa-cel. The Food and Drug Administration is expected to make a decision in early December and has a deadline of December 8. The agency appears poised to follow the MHRA and approve the treatment, with its advisors confident of the drug’s efficacy and benefit but wary of theoretical unintended consequences of genetic modifications.
You’re familiar with the states of matter we encounter daily – such as solid, liquid, and gas – but in more exotic and extreme conditions, new states can appear, and scientists from the US and China found one earlier this year.
They’re calling it the chiral bose-liquid state, and as with every new arrangement of particles we discover, it can tell us more about the fabric and the mechanisms of the Universe around us – and in particular, at the super-small quantum scale.
States of matter describe how particles can interact with one another, giving rise to structures and various ways of behaving. Lock atoms in place, and you have a solid. Allow them to flow, you have a liquid or gas. Force charged partnerships apart, you have a plasma.
A set of novel attack methods has been demonstrated against Google Workspace and the Google Cloud Platform that could be potentially leveraged by threat actors to conduct ransomware, data exfiltration, and password recovery attacks.
“Starting from a single compromised machine, threat actors could progress in several ways: they could move to other cloned machines with GCPW installed, gain access to the cloud platform with custom permissions, or decrypt locally stored passwords to continue their attack beyond the Google ecosystem,” Martin Zugec, technical solutions director at Bitdefender, said in a new report.
A prerequisite for these attacks is that the bad actor has already gained access to a local machine through other means, prompting Google to mark the bug as not eligible for fixing “since it’s outside of our threat model and the behavior is in line with Chrome’s practices of storing local data.”
